Attached files
| file | filename |
|---|---|
| S-1MEF - S-1MEF - KalVista Pharmaceuticals, Inc. | d907686ds1mef.htm |
| EX-5.1 - EX-5.1 - KalVista Pharmaceuticals, Inc. | d907686dex51.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-1 of our report dated April 6, 2015 relating to the financial statements of Carbylan Therapeutics, Inc., which appears in Amendment No. 2 to the Registration Statement on Form S-1 (No. 333-201278). We also consent to the reference to us under the heading “Experts” in Amendment No. 2 to the Registration Statement on Form S-1 incorporated by reference in this Registration Statement.
/s/ PricewaterhouseCoopers LLP
San Jose, California
April 8, 2015